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Abstract
 
Immature dendritic cells (DCs) constitutively take up large volumes of fluid by macropinocy-
tosis and concentrate the macrosolutes in the endocytic compartment. This concentration
mechanism that is the basis of their high capacity to present soluble antigens requires that DCs
be capable of rapidly exchanging water across their membranes. We report that two members
of the aquaporin family, AQP3 and AQP7, are expressed in immature DCs and are downregu-
lated after maturation. Treatment of DCs with 
 
p
 
-chloromercuribenzenesulphonate (pCMBS),
a mercuric drug that blocks aquaporins, inhibited uptake and concentration of macrosolutes
taken up by fluid phase endocytosis and led to dramatic cell swelling. In contrast, pCMBS did
not affect receptor-mediated endocytosis via the mannose receptor. These findings indicate that
aquaporins represent essential elements of a volume control mechanism that allows DCs to
concentrate macrosolutes taken up via macropinocytosis.
Key words: dendritic cells • ﬂuid phase endocytosis • aquaporins • antigen uptake •
volume control
 
Introduction
 
A high endocytic capacity is a fundamental property of im-
mature dendritic cells (DCs)
 
 
 
and is instrumental in allowing
efficient uptake and presentation of incoming antigens.
This endocytic activity is expressed at the highest level in
the immature stage and is lost as DCs mature and migrate
to the secondary lymphoid organs (1). Immature mono-
cyte-derived DCs can capture soluble antigens via two dis-
tinct mechanisms. The first is represented by receptors such
as the mannose receptor (MR) and Fc
 
g
 
RII, which allow
efficient uptake of mannosylated antigens or immune com-
plexes via classical clathrin-mediated endocytosis (2–4).
The second mechanism of antigen uptake is macropinocy-
tosis. Whereas in other cells such as macrophages or epithe-
lial cells macropinocytosis is induced only transiently by
growth factors or phorbol ester (5–7), in immature DCs,
macropinocytosis occurs in a constitutive fashion and at a
high rate and allows continuous capture of macrosolutes
present in the fluid phase (2). The macrosolutes that are
taken up in the fluid phase accumulate with time in the en-
docytic compartment, where they are loaded on newly
synthesized and recycling MHC class II molecules (8) but
may also be released into the cytosol, where they become
accessible to the class I antigen presentation pathway (9).
It was estimated that in one hour, a DC can take up as
much fluid as its own cell volume (2). To explain how im-
mature DCs could maintain their volume in spite of such
an enormous fluid intake, we hypothesized that they
should possess mechanisms to allow rapid exchange of salts
and water through their membranes. These mechanisms
would at the same time maintain cell volume and concen-
trate macrosolutes.
Cells regulate their volumes by selective transport of ions
and water. The concerted action of amiloride-sensitive so-
dium channels and of anion antiporters results in the net
transport of NaCl through the membrane (10–12). Water
follows this salt transport passively, but its diffusion is slow
and can be rate limiting. In cells that require a high capacity
for water transport such as epithelial cells of the kidney and
erythrocytes, this process is facilitated by specific channels
known as aquaporins (13). Aquaporins can be divided into
two groups depending on structural and functional proper-
ties. AQP3, AQP7, and AQP9 are structurally related to
the bacterial glycerol facilitator. AQP3 and AQP7 are per-
meable to water as well as to small neutral solutes such as
urea and glycerol, whereas AQP9 transports urea but not
glycerol. The other group of aquaporins is structurally re-
lated to the bacterial water channel. With the exception of
AQP4, all aquaporins are inhibited by the organomercurial
sulphydryl-reactive reagent 
 
p
 
-chloromercuribenzenesulph-
 
onate (pCMBS) that binds to critical cysteine residues of
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the water channel (14–16). This drug does not alter cell mem-
brane conductance to the major ions of the intra- or extra-
cellular fluids (17, 18).
We report here that two aquaporins, AQP3 and AQP7,
are expressed in immature DCs and are downregulated
upon DC maturation. The fact that pCMBS can reversibly
inhibit fluid phase but not receptor-mediated endocytosis
indicates that aquaporins play an essential role in the pro-
cess of antigen uptake and concentration via fluid phase
macropinocytosis.
 
Materials and Methods
 
Media and Reagents.
 
The medium used throughout was
RPMI 1640 supplemented with 2 mM 
 
l
 
-glutamine, 1% nones-
sential amino acids, 1% pyruvate, 50 
 
m
 
g/ml kanamycin (GIBCO
BRL), 5 
 
3 
 
10
 
2
 
5
 
 M 2-ME (Merck), and 10% FCS (Hyclone
Labs., Inc.). Human recombinant IL-4 was produced by PCR
cloning and expression in the myeloma-based expression system
(19). GM-CSF (Leucomax) was purchased from Novartis. TGF-
 
b
 
was purchased from R & D Systems, Inc. Lucifer yellow CH
potassium salt (LY) and lysine-fixable FITC–dextran (DX; 
 
M
 
r
 
 
 
5
 
40,000) was purchased from Molecular Probes, Inc. as lyophilized
powder, reconstituted in RPMI buffered with 25 mM Hepes,
and spun in a microfuge before use to remove
 
 
 
aggregates. Man-
nan from 
 
Saccharomyces cerevisiae
 
, pCMBS, LPS, 
 
b
 
-ME, and 5-(N,N-
dimethyl) amiloride (DMA) was purchased from Sigma Chemical
Co.
 
 
 
Purified rabbit anti–rat aquaporin 3 antiserum was purchased
from Alpha Diagnostic International.
 
Generation of Immature and Mature DCs.
 
DCs were generated
from human PBMCs as described (3) with minor modifications.
In brief, monocytes were purified by positive selection using
anti-CD14–conjugated magnetic microbeads (Miltenyi Biotec).
To obtain immature DCs, the CD14
 
1
 
 cells (
 
z
 
99% pure) were
cultured at 3 
 
3 
 
10
 
5
 
 per milliliter
 
 
 
in RPMI–10% FCS supple-
mented with 50 ng/ml GM-CSF and 1,000 U/ml human re-
combinant IL-4 for 7 d. DC maturation was induced by addition
of 1 
 
m
 
g/ml of LPS (from 
 
Salmonella abortus equi
 
) for 40 h. Mac-
rophages were generated from monocytes cultured for 10 d in
RPMI–20% human serum and 10 ng/ml M-CSF (R & D Sys-
tems, Inc.). TGF-
 
b
 
 (R & D Systems, Inc.) was used at 10 ng/ml.
 
Quantitation of Endocytosis in Single Cells by FACS
 
®
 
 Analysis.
 
Cells were incubated in RPMI–10% FCS buffered with 25
mM Hepes at 37
 
8
 
C. FITC–DX and LY were added at a final
concentration of 1 mg/ml. After different incubation times, the
cells were washed four times with cold PBS containing 1% FCS
and 0.01% NaN
 
3 
 
and were analyzed on a FACScan™ (Becton
Dickinson) using propidium iodide to exclude dead cells. The
background (cells pulsed at 0
 
8
 
C) was subtracted. In some experi-
ments, the cells were incubated for 5 min with different concen-
trations of pCMBS and/or DMA before adding the marker.
 
Reverse Transcriptase–PCR.
 
Total RNA was extracted using
RNAzol B (Tel-Test, Inc.). Single-stranded cDNA was synthe-
sized from 2 
 
m
 
g of total RNA using AMV reverse transcriptase
(RT; Promega Corp.). Primers used for the PCR were: AQP1,
5
 
9
 
-CATGGCCAGCGAGTTCAAG and 5
 
9
 
-CTGTGAGGTC-
ACTGCTGCG, amplifying a 719-bp product; AQP3, 5
 
9
 
-ATG-
GGTCGACAGAAGGAGCT and 5
 
9
 
-TCAGATCTGCTCCT-
TGTGCT, amplifying an 879-bp product; AQP7, 5
 
9
 
-GTC-
TCCTGGTCCGTGATAG and 5
 
9
 
-CTTCATACGCCACA-
GAATCC, amplifying an 834-bp product; AQP9, 5
 
9
 
-ATG-
CAGCCTGAGGGAGCAG and 5
 
9
 
-CAGAGCTGAGCATGC-
 
CACT, amplifying a 905-bp product; and 
 
b
 
-actin, 5
 
9
 
-ACA-
CTGTGCCCATCTACGAGGGG and 5
 
9
 
-ATGATGGAGTTG-
AAGGTAGTTTCGTGGAT, amplifying a 340-bp product. The
PCR was performed in a DNA thermal cycler (Perkin-Elmer
Corp.). We performed 30 cycles for AQP3 and AQP7 and 25 cy-
cles for AQP9 using the following conditions: 10 s at 94
 
8
 
C, 50 s
at 63
 
8
 
C, and 50 s at 72
 
8
 
C. 
 
b
 
-Actin mRNA amplification was
performed on the cDNA as a positive control for reaction effi-
ciency and was done for 25 cycles.
 
Immunoblotting.
 
Cells (5 
 
3
 
 10
 
6
 
) were lysed at 4
 
8
 
C in lysis
buffer (100 mM Tris/HCL, pH 7.4, 150 mM NaCl, 1% Triton
X-100, 5 mM EDTA, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin, and 10
 
m
 
g/ml leupeptin). Lysates were solved by 10% SDS-PAGE under
reducing conditions, and proteins were transferred to nitrocellu-
lose membranes (Hybond-C super; Amersham). After blocking
with PBS/0.1% Tween/5% nonfat dry milk, the membrane was
incubated with rabbit anti–rat AQP3 antiserum followed by
horseradish peroxidase–conjugated goat anti–rabbit IgG (South-
ern Biotechnology Associates). Proteins were visualized by
chemiluminescence using ECL detection reagents (Amersham).
 
Results
 
AQP3 and AQP7 Are Expressed in Immature DCs and
Downregulated upon Maturation.
 
Preliminary experiments
using RT-PCR revealed that AQP3, AQP7, and AQP9
Figure 1. AQP3 and AQP7 are selectively expressed in immature DCs
and downregulated after maturation. (A) RT-PCR results showing AQP3,
AQP7, AQP9, and b-actin expression in monocytes (Mo), immature DCs
(iDC), LPS-matured DCs (mDC), macrophages (Mf), monocytes cul-
tured with GM-CSF and TGF-b (GM-CSF-TGF-b), GM-CSF, IL-4,
and TGF-b (GM-CSF-IL4-TGF-b), DAUDI, and K-562. One represen-
tative experiment out of six performed with cDNA from different donors.
(B) Western blot with rabbit polyclonal anti-AQP3 antiserum (300 mg
protein per lane). One representative experiment out of three performed. 
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mRNAs were present in immature DCs, whereas AQP1
and AQP2 were absent. As shown in Fig. 1 A, the expres-
sion of AQP3 and AQP7 is developmentally regulated in
monocyte-derived DCs. These aquaporins were absent in
monocytes, which represent the precursors of immature
DCs, but were induced when monocytes differentiated
into immature DCs in cultures supplemented with GM-
CSF and IL-4 and were downregulated when DCs ma-
tured in response to LPS. AQP3 and AQP7 were not ex-
pressed in macrophages but were expressed in monocytes
cultured with GM-CSF, IL-4, and TGF-
 
b
 
, a cytokine
combination that promotes generation of Langerhans cells
(20). AQP3 and AQP7 were also expressed in monocytes
cultured with GM-CSF and TGF-
 
b
 
, indicating that IL-4
is not required for their induction. In contrast, AQP9
mRNA was detected in all CD14-derived cells and was not
influenced by the maturation stage.
The presence of AQP3 protein was studied by Western
blot with a specific antiserum (Fig. 1 B). This analysis con-
firmed that the highest levels of AQP3 protein were
present in immature DCs and showed that this level de-
creased upon maturation. Monocytes and macrophages did
not express AQP3 protein at detectable levels. Altogether,
these results indicate that AQP3 and AQP7 expression is
developmentally regulated in DCs and decreases after mat-
uration as does macropinocytosis (2).
 
pCMBS Inhibits Uptake and Concentration of Macrosolutes Taken
up by Fluid Phase But Not by Receptor-mediated Endocytosis.
 
We have previously shown that in immature DCs, LY is taken
up exclusively by fluid phase endocytosis, whereas FITC–DX
is taken up via both fluid phase and MR-mediated endocytosis
(2). pCMBS is a mercuric drug that inhibits AQP channel
function by binding to two cysteine residues, an effect that
leads to a block of the aqueous pore and which can be re-
versed by reducing reagents such as 
 
b
 
-ME (14–16). We tested
whether in immature DCs pCMBS could differentially affect
the uptake and accumulation of macrosolutes taken up via
fluid phase versus receptor-mediated endocytosis.
As shown in Fig. 2 A, pCMBS inhibited the uptake of
LY by immature DCs up to 90%, whereas in monocytes,
 
which show a 20-fold lower LY uptake, the inhibition was
only 30% (Fig. 2 B). In contrast to the dramatic inhibition
of LY uptake, the uptake of FITC–DX by immature DCs
was only slightly affected by pCMBS (
 
z
 
10–15%). This
small decrease reflects the small contribution of macropi-
nocytosis to FITC–DX uptake that occurs mainly via MR.
Figure 2. pCMBS blocks fluid phase but not receptor-mediated en-
docytosis in immature DCs. (A) Time-dependent accumulation of LY in
immature DCs in the absence (h) or presence of 50 (j) or 100 mM (m)
of pCMBS. (B) Time-dependent accumulation of LY in monocytes in
the absence (h) or presence of 100 mM of pCMBS (m). (C) Accumula-
tion of FITC–DX in immature DCs in the absence (h, j) or presence
(n, m) of 100 mM of pCMBS. The experiment was done in the absence
(h, n) or presence (j, m) of 2 mg/ml of mannan to block MR. (D) Ad-
ditive inhibitory effect of pCMBS and DMA on LY accumulation in im-
mature DCs. Immature DCs were incubated with LY for 30 min in the
presence of different concentrations of pCMBS alone (j) or with added
DMA at 125 mM (d) or 500 mM (.).
Figure 3. Morphological changes induced by pCMBS treatment of immature DCs. Representative electron micrographs of immature DCs exposed
for 15 min to 1 mg/ml of FITC–DX in the absence (A) or presence of 100 mM pCMBS (B and C). 
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Indeed, when MR was blocked by high concentrations of
mannan, the residual uptake of FITC–DX (which was then
entirely mediated by fluid phase endocytosis) could be
blocked by pCMBS up to 
 
z
 
80% (Fig. 2 C). These results
indicate that pCMBS inhibits uptake and concentration of
macrosolutes taken up via fluid phase endocytosis, whereas
it does not interfere with receptor-mediated endocytosis.
Macropinocytosis can also be inhibited by amiloride and
amiloride analogues, which inhibit Na
 
1
 
/H
 
1
 
 exchange (2, 7).
Treatment with DMA inhibited LY uptake as with pCMBS,
and the two drugs showed additive effects when used at sub-
optimal concentrations (Fig. 2 D). These results suggest that
uptake and concentrations of fluid phase markers requires
both aquaporins and amiloride-sensitive Na
 
1
 
/H
 
1
 
 channels.
 
Loss of Volume Control in DCs Treated with pCMBS.
 
The inhibition of fluid phase uptake after treatment with
pCMBS was accompanied by a prominent swelling of DCs.
pCMBS-treated DCs showed increased size, loss of veils,
and plumpness (Fig. 3). The drug-induced swelling was ac-
celerated in the presence of an oncotic load. If pCMBS was
added in the presence of medium alone, swelling occurred
slowly within 2 h. In contrast, in the presence of 1 mg/ml
FITC–DX (or DX alone), swelling occurred rapidly within
5 min (Fig. 4 A). By measuring the diameter of cells in sus-
 
pension, the increase in cell volume was estimated to be on
average 3.7-fold (i.e., from 1,000 to 3,760 
 
m
 
m
 
3
 
). This effect
cannot be explained by the osmotic gradient induced by
FITC–DX but is rather due to the colloid oncotic pressure
of the DX macromolecules (
 
M
 
r 
 
5 
 
40,000). Importantly, the
effects of pCMBS on fluid phase endocytosis and cell vol-
ume could be reversed by addition of 
 
b
 
-ME, which is
known to reverse the effect of the drug, indicating that the
effect observed was not due to toxicity (Fig. 4, B and C). In
contrast, incubation with DMA caused a rapid and marked
shrinkage of the cell that was independent of an oncotic
load and led with time to cell death (data not shown).
 
Discussion
 
We have shown that aquaporins are essential compo-
nents of a volume regulatory system that acts in immature
DCs to balance the high volume of fluid taken up by con-
stitutive macropinocytosis. In DCs, this system is instru-
mental to allow sustained capture and concentration of an-
tigens present in the fluid phase (2).
The large volume of fluid that is continuously taken up
via macropinocytosis must be eliminated by the DC to
maintain its volume and to avoid swelling. As discussed by
Swanson (5), the fluid taken up by macropinocytosis cannot
be simply eliminated by recycling vesicles, as these vesicles
are much smaller than the macropinosomes and therefore
will recycle membrane more efficiently than fluid. Conse-
quently, this process will lead to an increase in the mem-
brane tension of the maturing macropinosome (21). This
stress may lead to bursting of some pinosomes, thus account-
ing for the striking finding that soluble antigens taken up via
macropinocytosis can gain access to the class I presentation
pathway (9). How can macropinocytosing DCs cope with
the problem of maintaining their volume? Previous work has
shown that amiloride blocks macropinocytosis in both en-
dothelial cells (7) and immature DCs (2), suggesting a role
for the amiloride-sensitive epithelial sodium channel (ENaC;
reference 22). These channels can be activated by various
mechanisms, including an increase in membrane tension,
and thus provide a plausible mechanism for increasing the
transport of Na
 
1
 
 in macropinosomes after mechanical stress
(23, 24). Interestingly, we found that the ENaC regulatory 
 
g
 
subunit is highly expressed in immature DCs and downregu-
lated after DC maturation (our unpublished data). 
In this study, we have identified aquaporins as a second
essential component in this volume-controlling system. We
have shown that AQP3 and AQP7 are highly expressed in
immature DCs (coincident with the high level of macropi-
nocytosis) and are downregulated upon maturation (coinci-
dent with a downregulation of macropinocytosis). Further-
more, treatment of immature DCs with pCMBS results in
the selective and reversible block of macropinocytosis but
not of receptor-mediated endocytosis, demonstrating that
aquaporins have a selective effect on macropinocytosis. In
contrast to AQP3 and AQP7, AQP9 is constitutively ex-
pressed in leukocytes (25) and is present throughout DC
development from monocytes to mature DCs. We do not
Figure 4. Reversibility of the pCMBS effect after its removal or neutral-
ization. (A) Kinetics of swelling of immature DCs incubated with 1 mg/ml
of DX (n), with 100 mM pCMBS (d), or with both DX and pCMBS (j).
(B and C) Immature DCs were incubated with 1 mg/ml of DX in the ab-
sence (untreated) or presence of pCMBS. After 30 min, pCMBS was either
left in culture (pCMBS) or neutralized by adding b-ME (pCMBS/b-ME)
or removed by washing and neutralized (pCMBS/washed/b-ME). After a
further 15 min, cell size (B) and uptake of LY (C) were measured. 
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have a way to address the relative importance of the three
aquaporins. However, the regulated expression of AQP3
and AQP7 in immature DCs is compatible with their
prominent role in allowing immature DCs to cope with
the increased water turnover related to macropinocytosis.
Based on these observations, we propose the following
model to explain how DCs can concentrate macrosolutes.
In immature DCs, the high load of water and solutes taken
in via constitutive macropinocytosis is balanced by a high
activity of volume regulating channels. These include: (a)
the amiloride sensitive Na1/H1 channels that increase the
transport of ions and (b) the aquaporins that facilitate the
flow of water following the salt gradient. This mechanism
is geared to allow efficient presentation of soluble antigens
and illustrates how DCs can adapt their physiology to func-
tion as professional APCs. It is tempting to speculate that
aquaporins may also participate in other aspects of DC
function, such as the release of small endocytosed mole-
cules into the cytosol for class I–restricted presentation.
We thank Federica Sallusto and Jean Pieters for critical reading and
comments and Dr. Fred Gudat and Mrs. Ivon Litzisdorf (Institute
of Pathology, University of Basel) for electron microscopy. 
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